 | • レポートコード：MRC2102QY11799 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の肺用ドラッグデリバリーシステム市場について種類別（ネブライザー、ドライパウダー吸入器（DPI）、定量吸入器（MDI））、用途別（COPD、喘息、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・肺用ドラッグデリバリーシステム市場の概要 ・世界の主要地域別肺用ドラッグデリバリーシステム市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の肺用ドラッグデリバリーシステム市場規模2015-2026：種類別（ネブライザー、ドライパウダー吸入器（DPI）、定量吸入器（MDI）） ・世界の肺用ドラッグデリバリーシステム市場規模2015-2026：用途別（COPD、喘息、その他） ・肺用ドラッグデリバリーシステムの米国市場規模2015-2020 ・肺用ドラッグデリバリーシステムのヨーロッパ市場規模2015-2020 ・肺用ドラッグデリバリーシステムの中国市場規模2015-2020 ・肺用ドラッグデリバリーシステムの日本市場規模2015-2020 ・肺用ドラッグデリバリーシステムの東南アジア市場規模2015-2020 ・肺用ドラッグデリバリーシステムのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・肺用ドラッグデリバリーシステムの製造コスト分析 ・販売チャネル、流通業者、顧客 ・肺用ドラッグデリバリーシステムの市場動向・機会・課題 ・調査の結論 |
Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.
Market Analysis and Insights: Global Pulmonary Drug Delivery Systems Market
The global Pulmonary Drug Delivery Systems market size is projected to reach US$ 3741.8 million by 2026, from US$ 2923.3 million in 2020, at a CAGR of 4.2% during 2021-2026.
Global Pulmonary Drug Delivery Systems Scope and Market Size
The global Pulmonary Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Pulmonary Drug Delivery Systems market is segmented into
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Segment by Application, the Pulmonary Drug Delivery Systems market is segmented into
COPD
Asthma
Others
The Pulmonary Drug Delivery Systems market is analysed and market size information is provided by regions (countries). Segment by Application, the Pulmonary Drug Delivery Systems market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pulmonary Drug Delivery Systems Market Share Analysis
Pulmonary Drug Delivery Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pulmonary Drug Delivery Systems business, the date to enter into the Pulmonary Drug Delivery Systems market, Pulmonary Drug Delivery Systems product introduction, recent developments, etc.
The major vendors covered:
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
1 Pulmonary Drug Delivery Systems Market Overview
1.1 Pulmonary Drug Delivery Systems Product Scope
1.2 Pulmonary Drug Delivery Systems Segment by Type
1.2.1 Global Pulmonary Drug Delivery Systems Sales by Type (2020-2026)
1.2.2 Nebulizers
1.2.3 Dry Powder Inhaler (DPI)
1.2.4 Metered Dose Inhaler (MDI)
1.3 Pulmonary Drug Delivery Systems Segment by Application
1.3.1 Global Pulmonary Drug Delivery Systems Sales Comparison by Application (2020-2026)
1.3.2 COPD
1.3.3 Asthma
1.3.4 Others
1.4 Pulmonary Drug Delivery Systems Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pulmonary Drug Delivery Systems Sales Growth Rate (2015-2026)
1.4.2 Global Pulmonary Drug Delivery Systems Revenue and Growth Rate (2015-2026)
1.4.3 Global Pulmonary Drug Delivery Systems Price Trends (2015-2026)
2 Pulmonary Drug Delivery Systems Estimate and Forecast by Region
2.1 Global Pulmonary Drug Delivery Systems Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pulmonary Drug Delivery Systems Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2015-2020)
2.2.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2015-2020)
2.3 Global Pulmonary Drug Delivery Systems Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pulmonary Drug Delivery Systems Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pulmonary Drug Delivery Systems Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pulmonary Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.2 Europe Pulmonary Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.3 China Pulmonary Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.4 Japan Pulmonary Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pulmonary Drug Delivery Systems Estimates and Projections (2015-2026)
2.4.6 India Pulmonary Drug Delivery Systems Estimates and Projections (2015-2026)
3 Global Pulmonary Drug Delivery Systems Competition Landscape by Players
3.1 Global Top Pulmonary Drug Delivery Systems Players by Sales (2015-2020)
3.2 Global Top Pulmonary Drug Delivery Systems Players by Revenue (2015-2020)
3.3 Global Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Drug Delivery Systems as of 2019)
3.4 Global Pulmonary Drug Delivery Systems Average Price by Company (2015-2020)
3.5 Manufacturers Pulmonary Drug Delivery Systems Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pulmonary Drug Delivery Systems Players (Opinion Leaders)
4 Global Pulmonary Drug Delivery Systems Market Size by Type
4.1 Global Pulmonary Drug Delivery Systems Historic Market Review by Type (2015-2020)
4.1.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
4.1.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2015-2020)
4.1.3 Global Pulmonary Drug Delivery Systems Price by Type (2015-2020)
4.2 Global Pulmonary Drug Delivery Systems Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Type (2021-2026)
4.2.2 Global Pulmonary Drug Delivery Systems Revenue Forecast by Type (2021-2026)
4.2.3 Global Pulmonary Drug Delivery Systems Price Forecast by Type (2021-2026)
5 Global Pulmonary Drug Delivery Systems Market Size by Application
5.1 Global Pulmonary Drug Delivery Systems Historic Market Review by Application (2015-2020)
5.1.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
5.1.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2015-2020)
5.1.3 Global Pulmonary Drug Delivery Systems Price by Application (2015-2020)
5.2 Global Pulmonary Drug Delivery Systems Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Application (2021-2026)
5.2.2 Global Pulmonary Drug Delivery Systems Revenue Forecast by Application (2021-2026)
5.2.3 Global Pulmonary Drug Delivery Systems Price Forecast by Application (2021-2026)
6 United States Pulmonary Drug Delivery Systems Market Facts & Figures
6.1 United States Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
6.2 United States Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
6.3 United States Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
7 Europe Pulmonary Drug Delivery Systems Market Facts & Figures
7.1 Europe Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
7.2 Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
7.3 Europe Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
8 China Pulmonary Drug Delivery Systems Market Facts & Figures
8.1 China Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
8.2 China Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
8.3 China Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
9 Japan Pulmonary Drug Delivery Systems Market Facts & Figures
9.1 Japan Pulmonary Drug Delivery Systems Sales Market Share by Company (3015-3030)
9.2 Japan Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
9.3 Japan Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
10 Southeast Asia Pulmonary Drug Delivery Systems Market Facts & Figures
10.1 Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
11 India Pulmonary Drug Delivery Systems Market Facts & Figures
11.1 India Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
11.2 India Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
11.3 India Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pulmonary Drug Delivery Systems Business
12.1 3M
12.1.1 3M Corporation Information
12.1.2 3M Business Overview
12.1.3 3M Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.1.4 3M Pulmonary Drug Delivery Systems Products Offered
12.1.5 3M Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Pulmonary Drug Delivery Systems Products Offered
12.2.5 GSK Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Business Overview
12.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca Pulmonary Drug Delivery Systems Products Offered
12.3.5 AstraZeneca Recent Development
12.4 Cipla
12.4.1 Cipla Corporation Information
12.4.2 Cipla Business Overview
12.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cipla Pulmonary Drug Delivery Systems Products Offered
12.4.5 Cipla Recent Development
12.5 Chiesi
12.5.1 Chiesi Corporation Information
12.5.2 Chiesi Business Overview
12.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Chiesi Pulmonary Drug Delivery Systems Products Offered
12.5.5 Chiesi Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Corporation Information
12.6.2 Boehringer Ingelheim Business Overview
12.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Products Offered
12.6.5 Boehringer Ingelheim Recent Development
12.7 Aptar
12.7.1 Aptar Corporation Information
12.7.2 Aptar Business Overview
12.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Aptar Pulmonary Drug Delivery Systems Products Offered
12.7.5 Aptar Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Business Overview
12.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis Pulmonary Drug Delivery Systems Products Offered
12.8.5 Novartis Recent Development
12.9 Philips Respironics
12.9.1 Philips Respironics Corporation Information
12.9.2 Philips Respironics Business Overview
12.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Philips Respironics Pulmonary Drug Delivery Systems Products Offered
12.9.5 Philips Respironics Recent Development
12.10 Omron Healthcare
12.10.1 Omron Healthcare Corporation Information
12.10.2 Omron Healthcare Business Overview
12.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Products Offered
12.10.5 Omron Healthcare Recent Development
12.11 PARI
12.11.1 PARI Corporation Information
12.11.2 PARI Business Overview
12.11.3 PARI Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.11.4 PARI Pulmonary Drug Delivery Systems Products Offered
12.11.5 PARI Recent Development
12.12 Skyepharma
12.12.1 Skyepharma Corporation Information
12.12.2 Skyepharma Business Overview
12.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Skyepharma Pulmonary Drug Delivery Systems Products Offered
12.12.5 Skyepharma Recent Development
12.13 CareFusion
12.13.1 CareFusion Corporation Information
12.13.2 CareFusion Business Overview
12.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.13.4 CareFusion Pulmonary Drug Delivery Systems Products Offered
12.13.5 CareFusion Recent Development
12.14 Shanghai Huarui
12.14.1 Shanghai Huarui Corporation Information
12.14.2 Shanghai Huarui Business Overview
12.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Products Offered
12.14.5 Shanghai Huarui Recent Development
12.15 Taian Character
12.15.1 Taian Character Corporation Information
12.15.2 Taian Character Business Overview
12.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Taian Character Pulmonary Drug Delivery Systems Products Offered
12.15.5 Taian Character Recent Development
12.16 Chia Tai Tianqing
12.16.1 Chia Tai Tianqing Corporation Information
12.16.2 Chia Tai Tianqing Business Overview
12.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Products Offered
12.16.5 Chia Tai Tianqing Recent Development
13 Pulmonary Drug Delivery Systems Manufacturing Cost Analysis
13.1 Pulmonary Drug Delivery Systems Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Systems
13.4 Pulmonary Drug Delivery Systems Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pulmonary Drug Delivery Systems Distributors List
14.3 Pulmonary Drug Delivery Systems Customers
15 Market Dynamics
15.1 Pulmonary Drug Delivery Systems Market Trends
15.2 Pulmonary Drug Delivery Systems Opportunities and Drivers
15.3 Pulmonary Drug Delivery Systems Market Challenges
15.4 Pulmonary Drug Delivery Systems Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pulmonary Drug Delivery Systems Sales (M Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Pulmonary Drug Delivery Systems Sales (M Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Pulmonary Drug Delivery Systems Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pulmonary Drug Delivery Systems Sales (M Units) by Region (2015-2020)
Table 5. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2015-2020)
Table 6. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pulmonary Drug Delivery Systems Revenue Share by Region (2015-2020)
Table 8. Global Pulmonary Drug Delivery Systems Sales (M Units) Forecast by Region (2021-2026)
Table 9. Global Pulmonary Drug Delivery Systems Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pulmonary Drug Delivery Systems Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pulmonary Drug Delivery Systems (M Units) of Key Companies (2015-2020)
Table 13. Global Pulmonary Drug Delivery Systems Sales Share by Company (2015-2020)
Table 14. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pulmonary Drug Delivery Systems Revenue Share by Company (2015-2020)
Table 16. Global Pulmonary Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Drug Delivery Systems as of 2019)
Table 17. Global Pulmonary Drug Delivery Systems Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Pulmonary Drug Delivery Systems Manufacturing Sites and Area Served
Table 19. Manufacturers Pulmonary Drug Delivery Systems Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pulmonary Drug Delivery Systems Players
Table 22. Global Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 23. Global Pulmonary Drug Delivery Systems Sales Share by Type (2015-2020)
Table 24. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pulmonary Drug Delivery Systems Price (M Units) by Type (2015-2020)
Table 26. Global Pulmonary Drug Delivery Systems Sales Share by Type (2021-2026)
Table 27. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pulmonary Drug Delivery Systems Revenue Share by Type (2021-2026)
Table 29. Global Pulmonary Drug Delivery Systems Price (M Units) by Type (2021-2026)
Table 30. Global Pulmonary Drug Delivery Systems Sales (M Units) by Application (2015-2020)
Table 31. Global Pulmonary Drug Delivery Systems Sales Share by Application (2015-2020)
Table 32. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pulmonary Drug Delivery Systems Price (M Units) by Application (2015-2020)
Table 34. Global Pulmonary Drug Delivery Systems Sales (M Units) by Application (2021-2026)
Table 35. Global Pulmonary Drug Delivery Systems Sales Share by Application (2021-2026)
Table 36. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pulmonary Drug Delivery Systems Revenue Share by Application (2021-2026)
Table 38. Global Pulmonary Drug Delivery Systems Price (M Units) by Application (2021-2026)
Table 39. United States Pulmonary Drug Delivery Systems Sales (M Units) by Company (2015-2020)
Table 40. United States Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 41. United States Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 42. United States Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 43. United States Pulmonary Drug Delivery Systems Sales (M Units) by Application (2015-2020)
Table 44. United States Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 45. Europe Pulmonary Drug Delivery Systems Sales (M Units) by Company (2015-2020)
Table 46. Europe Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 47. Europe Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 48. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 49. Europe Pulmonary Drug Delivery Systems Sales (M Units) by Application (2015-2020)
Table 50. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 51. China Pulmonary Drug Delivery Systems Sales (M Units) by Company (2015-2020)
Table 52. China Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 53. China Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 54. China Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 55. China Pulmonary Drug Delivery Systems Sales (M Units) by Application (2015-2020)
Table 56. China Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 57. Japan Pulmonary Drug Delivery Systems Sales (M Units) by Company (2015-2020)
Table 58. Japan Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 59. Japan Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 60. Japan Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 61. Japan Pulmonary Drug Delivery Systems Sales (M Units) by Application (2015-2020)
Table 62. Japan Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pulmonary Drug Delivery Systems Sales (M Units) by Company (2015-2020)
Table 64. Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 66. Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 68. Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 69. India Pulmonary Drug Delivery Systems Sales (M Units) by Company (2015-2020)
Table 70. India Pulmonary Drug Delivery Systems Sales Market Share by Company (2015-2020)
Table 71. India Pulmonary Drug Delivery Systems Sales (M Units) by Type (2015-2020)
Table 72. India Pulmonary Drug Delivery Systems Sales Market Share by Type (2015-2020)
Table 73. India Pulmonary Drug Delivery Systems Sales (M Units) by Application (2015-2020)
Table 74. India Pulmonary Drug Delivery Systems Sales Market Share by Application (2015-2020)
Table 75. 3M Corporation Information
Table 76. 3M Description and Business Overview
Table 77. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. 3M Pulmonary Drug Delivery Systems Product
Table 79. 3M Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GSK Pulmonary Drug Delivery Systems Product
Table 84. GSK Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AstraZeneca Pulmonary Drug Delivery Systems Product
Table 89. AstraZeneca Recent Development
Table 90. Cipla Corporation Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Cipla Pulmonary Drug Delivery Systems Product
Table 94. Cipla Recent Development
Table 95. Chiesi Corporation Information
Table 96. Chiesi Description and Business Overview
Table 97. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Chiesi Pulmonary Drug Delivery Systems Product
Table 99. Chiesi Recent Development
Table 100. Boehringer Ingelheim Corporation Information
Table 101. Boehringer Ingelheim Description and Business Overview
Table 102. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product
Table 104. Boehringer Ingelheim Recent Development
Table 105. Aptar Corporation Information
Table 106. Aptar Description and Business Overview
Table 107. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Aptar Pulmonary Drug Delivery Systems Product
Table 109. Aptar Recent Development
Table 110. Novartis Corporation Information
Table 111. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Novartis Description and Business Overview
Table 113. Novartis Pulmonary Drug Delivery Systems Product
Table 114. Novartis Recent Development
Table 115. Philips Respironics Corporation Information
Table 116. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Philips Respironics Description and Business Overview
Table 118. Philips Respironics Pulmonary Drug Delivery Systems Product
Table 119. Philips Respironics Recent Development
Table 120. Omron Healthcare Corporation Information
Table 121. Omron Healthcare Description and Business Overview
Table 122. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Omron Healthcare Pulmonary Drug Delivery Systems Product
Table 124. Omron Healthcare Recent Development
Table 125. PARI Corporation Information
Table 126. PARI Description and Business Overview
Table 127. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. PARI Pulmonary Drug Delivery Systems Product
Table 129. PARI Recent Development
Table 130. Skyepharma Corporation Information
Table 131. Skyepharma Description and Business Overview
Table 132. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Skyepharma Pulmonary Drug Delivery Systems Product
Table 134. Skyepharma Recent Development
Table 135. CareFusion Corporation Information
Table 136. CareFusion Description and Business Overview
Table 137. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. CareFusion Pulmonary Drug Delivery Systems Product
Table 139. CareFusion Recent Development
Table 140. Shanghai Huarui Corporation Information
Table 141. Shanghai Huarui Description and Business Overview
Table 142. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Shanghai Huarui Pulmonary Drug Delivery Systems Product
Table 144. Shanghai Huarui Recent Development
Table 145. Taian Character Corporation Information
Table 146. Taian Character Description and Business Overview
Table 147. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Taian Character Pulmonary Drug Delivery Systems Product
Table 149. Taian Character Recent Development
Table 150. Chia Tai Tianqing Corporation Information
Table 151. Chia Tai Tianqing Description and Business Overview
Table 152. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product
Table 154. Chia Tai Tianqing Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Pulmonary Drug Delivery Systems Distributors List
Table 158. Pulmonary Drug Delivery Systems Customers List
Table 159. Pulmonary Drug Delivery Systems Market Key Trends
Table 160. Pulmonary Drug Delivery Systems Key Opportunities and Drivers
Table 161. Pulmonary Drug Delivery Systems Market Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Drug Delivery Systems Product Picture
Figure 2. Global Pulmonary Drug Delivery Systems Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pulmonary Drug Delivery Systems Market Share by Application in 2020 & 2026
Figure 6. COPD Examples
Figure 7. Asthma Examples
Figure 8. Others Examples
Figure 9. Global Pulmonary Drug Delivery Systems Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Pulmonary Drug Delivery Systems Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pulmonary Drug Delivery Systems Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pulmonary Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pulmonary Drug Delivery Systems Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Pulmonary Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pulmonary Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pulmonary Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pulmonary Drug Delivery Systems Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pulmonary Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pulmonary Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pulmonary Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pulmonary Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pulmonary Drug Delivery Systems Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pulmonary Drug Delivery Systems Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pulmonary Drug Delivery Systems Players Market Share by Revenue in Pulmonary Drug Delivery Systems 2015 & 2019
Figure 27. Pulmonary Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pulmonary Drug Delivery Systems Revenue Share by Type (2015-2020)
Figure 29. Global Pulmonary Drug Delivery Systems Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pulmonary Drug Delivery Systems Revenue Share by Application (2015-2020)
Figure 31. Global Pulmonary Drug Delivery Systems Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pulmonary Drug Delivery Systems Sales Market Share by Type in 2019
Figure 33. United States Pulmonary Drug Delivery Systems Sales Market Share by Type in 2019
Figure 34. Europe Pulmonary Drug Delivery Systems Sales Market Share by Company in 2019
Figure 35. Europe Pulmonary Drug Delivery Systems Sales Market Share by Type in 2019
Figure 36. Europe Pulmonary Drug Delivery Systems Sales Market Share by Application in 2019
Figure 37. China Pulmonary Drug Delivery Systems Sales Market Share by Company in 2019
Figure 38. China Pulmonary Drug Delivery Systems Sales Market Share by Type in 2019
Figure 39. China Pulmonary Drug Delivery Systems Sales Market Share by Application in 2019
Figure 40. Japan Pulmonary Drug Delivery Systems Sales Market Share by Company in 2019
Figure 41. Japan Pulmonary Drug Delivery Systems Sales Market Share by Type in 2019
Figure 42. Japan Pulmonary Drug Delivery Systems Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pulmonary Drug Delivery Systems Sales Market Share by Application in 2019
Figure 46. India Pulmonary Drug Delivery Systems Sales Market Share by Company in 2019
Figure 47. India Pulmonary Drug Delivery Systems Sales Market Share by Type in 2019
Figure 48. India Pulmonary Drug Delivery Systems Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Pulmonary Drug Delivery Systems
Figure 51. Manufacturing Process Analysis of Pulmonary Drug Delivery Systems
Figure 52. Pulmonary Drug Delivery Systems Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
バッカル錠ドラッグデリバリーシステムの世界市場レポート2020 Market Analysis and Insights: Global Buccal Drug Delivery Systems Market The global Buccal Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Buccal Drug Delivery Systems Scope and Market Size The glo…- 特発性肺線維症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Idiopathic Pulmonary Fibrosis Drug Market The global Idiopathic Pulmonary Fibrosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Idiopathic Pulmonary Fibrosis Drug Scope and M…
- 肺塞栓症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Pulmonary Embolism Drug Market The global Pulmonary Embolism Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pulmonary Embolism Drug Scope and Market Size The global Pulmonary E…
- 徐放性眼用ドラッグデリバリーシステムの世界市場レポート2020 Market Analysis and Insights: Global Sustained Release Ocular Drug Delivery Systems Market The global Sustained Release Ocular Drug Delivery Systems market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Sustained Release Ocul…
- RNA干渉（RNAi）ドラッグデリバリーの世界市場レポート2020 Market Analysis and Insights: Global RNA Interference (RNAi) Drug Delivery Market The global RNA Interference (RNAi) Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global RNA Interference (RNAi) Drug Delivery Sc…